I share @madamswer's skepticism on this one. I know it's chalk and cheese, but I'd hate to see RMD go down the (well trodden) path of firms like CAJ with their Enlitic acquisition.
Ann: ResMed to Acquire Brightree, page-42
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$34.11 |
Change
0.400(1.19%) |
Mkt cap ! $21.92B | |||
| Open | High | Low | Value | Volume |
| $34.20 | $34.34 | $34.02 | $60.82M | 1.781M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7996 | $34.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $34.16 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| RMD (ASX) Chart |